Skip to content

Comparison of different methods of airway management in patients undergoing laparoscopic surgeries.

Comparison of Supreme and Proseal Laryngeal Mask Airway in patients undergoing laparoscopic cholecystectomy - RACE

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2015/06/005919
Enrollment
80
Registered
2015-06-16
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Patients with Gall Bladder Stone disease for elective cholecystectomy were chosen. Pateints with mouth opening less than 2.5 cm,with upper respiratory tract infection were excluded.

Interventions

Intervention1: Supreme LMA: New supraglottic airway device that presents combined features pf Proseal LMA, Fastrach LMA and Unique LMA. Clinical and fibreoptic evaluation of SLMA showed easy insertion

Sponsors

Govt Medical College and Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Age group b/w 20 to 60 years 2. American Society of Anaesthesiologist (ASA) physical status I and II 3. Patients scheduled for elective laparoscopic cholecystectomy under general anaesthesia.

Exclusion criteria

Exclusion criteria: The following patients were excluded from the study. 1. Patients with known or predicted difficult airway or MPG III/IV. 2. Patients with mouth opening of less than 2.5 cm. . 3. Patients with history of upper respiratory tract infection. 4. Patients with increased risk of regurgitation and aspiration. 5. Patients with a body mass index (BMI) > 35 kg.m.-2 6. Patients unable to understand the study protocol.

Design outcomes

Primary

MeasureTime frame
Ease of insertion of equipment, Cuff Pressure of equipment, oropharyngeal leak pressureTimepoint: Time for successful insertion of equipment and time of insertion of orogastric tube

Secondary

MeasureTime frame
Any morbidity,adverse effectTimepoint: In first 24 hours

Countries

India

Contacts

Public ContactL K Anand

Government Medical College Hospital Chandigarh

lkanand11@yahoo.com9646121522

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026